About
We aim to reduce patient suffering from meniscus and articular cartilage injury or degeneration by creating unique regenerative joint preservation solutions. Our clinically validated biodegradable polymer and endogenous cartilage repair technology encourages the natural healing process of the body by facilitating regenerative repair of damaged tissue in areas with low regenerative capacity. Actifit is an implant specifically designed to support regeneration of meniscus defects through arthroscopic surgery and has significant potential to improve joint health and delay the need for full meniscus replacement. Patients experience pain relief and functional improvement up to 10 years. Our product CartiONE is the unique cartilage repair technology that uses endogenous chondrocytes in a single surgery. Our products have been validated in over 30 peer-reviewed clinical publications and cited in over 100 journal articles. Actifit is available in more than 30 countries.
Technologies
Keywords
Company Information
-
Employees 8
-
Founded 2005
-
Annual Revenue $16000000
Location
8 Bridle Close, Kingston upon Thames, England, United Kingdom, KT1 2HX
